Skip to main content

Rhenman & Partners Asset Management AB

13F filer · CIK 0001599882
Reported Aug 13, 2026
Net buyer this quarter
13F portfolio value$1.06BU.S. long equity reported on 13F
Positions9920 new · 7 closed
Net flow last quarter+$155MBuys minus sells
Top 10 positions weight25.1%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 13, 202699 positions
UNHUnitedhealth Group Inc$38.9M3.67%0.01%+105.7%Q4 2013
CVSCVS HEALTH Corp$28.9M2.73%0.02%-17.0%Q4 2013
AZNAstrazeneca PLC$28.5M2.69%Not reportedNewQ2 2026
MRKMerck & Co., Inc.$27.4M2.59%0.01%Not reportedQ4 2013
LLYELI LILLY & Co$26.8M2.53%0.00%-33.8%Q4 2013
ABBVAbbVie Inc.$24.4M2.30%0.01%+35.2%Q1 2014
ALHCAlignment Healthcare, Inc.$23.7M2.24%0.48%-5.4%Q3 2022
EWEdwards Lifesciences Corp$23.5M2.22%0.05%+59.5%Q1 2014
GILDGilead Sciences, Inc.$22.5M2.13%0.01%+6.3%Q4 2013
JAZZJazz Pharmaceuticals plc$21.1M1.99%0.14%+15.2%Q3 2014
BIIBBiogen Inc.$20.5M1.93%0.06%-13.1%Q4 2013
SYKStryker Corp$20.5M1.93%0.02%+36.0%Q1 2014
BSXBoston Scientific Corp$19.2M1.81%0.03%-27.9%Q4 2013
JNJJohnson & Johnson$18.4M1.74%0.00%Not reportedQ4 2013
GHGuardant Health, Inc.$17.3M1.63%0.09%-20.7%Q3 2019
REGNRegeneron Pharmaceuticals, Inc.$17.1M1.61%0.03%-43.1%Q4 2013
GKOSGLAUKOS Corp$16.6M1.57%0.20%+41.7%Q2 2016
BMRNBiomarin Pharmaceutical Inc$16.6M1.57%0.15%+40.3%Q4 2013
NRIXNurix Therapeutics, Inc.$16.6M1.57%0.66%+118.3%Q2 2024
NTRANatera, Inc.$16.6M1.56%0.04%+18.3%Q3 2022
MIRMMirum Pharmaceuticals, Inc.$16.3M1.54%0.22%+50.3%Q1 2024
INSMINSMED Inc$16.2M1.53%0.07%-4.9%Q2 2024
THCTenet Healthcare Corp$15.9M1.50%0.10%+57.8%Q2 2021
TMOThermo Fisher Scientific Inc.$15.8M1.49%0.01%-23.6%Q4 2013
CNCCentene Corp$15.7M1.48%0.05%Not reportedQ4 2013
AXSMAxsome Therapeutics, Inc.$15.4M1.46%0.12%-1.2%Q1 2023
DHRDanaher Corp$15.3M1.44%0.01%+344.6%Q4 2021
VRTXVertex Pharmaceuticals Inc / Ma$15.2M1.44%0.01%-29.4%Q2 2014
AVRAnteris Technologies Global Corp.$15.2M1.43%1.58%+7.0%Q1 2025
NBIXNeurocrine Biosciences Inc$14.5M1.37%0.08%-14.9%Q1 2016
PNTGPennant Group, Inc.$13.7M1.30%1.07%+34.9%Q4 2025
ISRGIntuitive Surgical Inc$13.7M1.30%0.01%-6.4%Q4 2013
ELVElevance Health, Inc.$13.5M1.27%0.02%+8.1%Q4 2014
LIVNLivaNova PLC$13.5M1.27%0.30%+5.8%Q4 2015
CORCencora, Inc.$13.2M1.25%0.02%-10.7%Q4 2013
CRLCharles River Laboratories International, Inc.$13M1.22%0.12%+120.0%Q3 2023
IDYAIDEAYA Biosciences, Inc.$12.8M1.21%0.36%+34.6%Q2 2024
MCKMckesson Corp$12.5M1.18%0.01%-1.8%Q4 2013
SNDXSyndax Pharmaceuticals Inc$12.2M1.16%0.63%+47.7%Q1 2024
BTSGBrightSpring Health Services, Inc.$11.6M1.09%0.08%+231.8%Q3 2025
MDTMedtronic plc$11.3M1.07%0.01%+61.1%Q4 2013
MLYSMineralys Therapeutics, Inc.$11.2M1.06%0.47%+58.3%Q3 2025
OSCROscar Health, Inc.$11.2M1.06%Not reported-40.6%Q3 2023
RPRXRoyalty Pharma plc$11M1.04%0.05%-15.5%Q4 2020
DXCMDexcom Inc$10.8M1.02%0.04%Not reportedQ4 2013
ALGNAlign Technology Inc$10.6M1.00%0.09%+740.0%Q4 2021
SYRESpyre Therapeutics, Inc.$10.6M1.00%0.14%NewQ2 2026
RLAYRelay Therapeutics, Inc.$10.6M1.00%0.26%+57.2%Q4 2022
ARWRArrowhead Pharmaceuticals, Inc.$10.4M0.98%0.09%-11.4%Q4 2025
AAgilent Technologies, Inc.$9.96M0.94%0.03%+200.0%Q4 2013
Q1 2026Reported May 14, 202686 positions
BSXBoston Scientific Corp$39.2M4.84%0.04%+44.9%Q4 2013
REGNRegeneron Pharmaceuticals, Inc.$37.2M4.59%0.05%-21.7%Q4 2013
LLYELI LILLY & Co$31M3.83%0.00%-20.1%Q4 2013
INSMINSMED Inc$26.1M3.22%0.07%+40.7%Q2 2024
CVSCVS HEALTH Corp$24.2M2.98%0.03%+0.3%Q4 2013
GILDGilead Sciences, Inc.$23.4M2.88%0.01%+33.0%Q4 2013
TMOThermo Fisher Scientific Inc.$20.3M2.51%0.01%+22.9%Q4 2013
BIIBBiogen Inc.$20M2.47%0.07%+18.1%Q4 2013
VRTXVertex Pharmaceuticals Inc / Ma$19.4M2.40%0.02%+26.9%Q2 2014
ALHCAlignment Healthcare, Inc.$18.6M2.29%0.51%+4.4%Q3 2022
ISRGIntuitive Surgical Inc$17M2.10%0.01%-23.2%Q4 2013
CORCencora, Inc.$16.5M2.03%0.03%-17.4%Q4 2013
SYKStryker Corp$15.7M1.94%0.01%Not reportedQ1 2014
ABBVAbbVie Inc.$15.6M1.92%0.00%-35.3%Q1 2014
VEEVVeeva Systems Inc$15M1.85%0.05%Not reportedQ1 2021
MCKMckesson Corp$14.6M1.80%0.01%-34.2%Q4 2013
JAZZJazz Pharmaceuticals plc$14.3M1.77%0.12%+2.5%Q3 2014
GHGuardant Health, Inc.$13.4M1.65%0.11%+81.3%Q3 2019
NBIXNeurocrine Biosciences Inc$13.3M1.64%0.10%-19.6%Q1 2016
EWEdwards Lifesciences Corp$13.1M1.61%0.03%-15.8%Q1 2014
MDGLMadrigal Pharmaceuticals, Inc.$12.6M1.55%0.10%+23.0%Q1 2019
UNHUnitedhealth Group Inc$12.3M1.52%0.01%-17.1%Q4 2013
PRCTPROCEPT BioRobotics Corp$11.9M1.47%0.83%-22.3%Q2 2023
BMRNBiomarin Pharmaceutical Inc$11.7M1.44%0.11%-3.7%Q4 2013
ABTAbbott Laboratories$11.5M1.42%0.01%Not reportedQ2 2016
ALNYAlnylam Pharmaceuticals, Inc.$11.4M1.41%0.03%-24.5%Q3 2014
RPRXRoyalty Pharma plc$11.2M1.38%0.06%+12.8%Q4 2020
AXSMAxsome Therapeutics, Inc.$10.8M1.33%0.12%-44.4%Q1 2023
NTRANatera, Inc.$10.3M1.27%0.04%+27.4%Q3 2022
THCTenet Healthcare Corp$10.2M1.26%0.06%-29.4%Q2 2021
ADPTAdaptive Biotechnologies Corp$9.99M1.23%0.45%+19.0%Q3 2025
LIVNLivaNova PLC$9.85M1.22%0.28%-18.4%Q4 2015
ELVElevance Health, Inc.$9.46M1.17%0.01%+115.3%Q4 2014
ARWRArrowhead Pharmaceuticals, Inc.$9.06M1.12%0.10%Not reportedQ4 2025
GKOSGLAUKOS Corp$9.04M1.12%0.14%-60.0%Q2 2016
IQVIqvia Holdings Inc.$9.04M1.12%0.03%+100.0%Q4 2022
SNDXSyndax Pharmaceuticals Inc$8.86M1.09%0.43%-22.1%Q1 2024
MIRMMirum Pharmaceuticals, Inc.$8.55M1.06%0.15%-12.9%Q1 2024
IDYAIDEAYA Biosciences, Inc.$8.51M1.05%0.29%+2.2%Q2 2024
PNTGPennant Group, Inc.$8.39M1.04%0.79%-22.9%Q4 2025
NUVLNuvalent, Inc.$8.32M1.03%2.59%-50.3%Q4 2022
WAYWaystar Holding Corp.$8.26M1.02%0.18%NewQ1 2026
AVRAnteris Technologies Global Corp.$7.98M0.99%1.48%+16.2%Q1 2025
MDTMedtronic plc$7.8M0.96%0.01%-69.6%Q4 2013
OSCROscar Health, Inc.$7.57M0.93%Not reported+153.9%Q3 2023
IOVAIovance Biotherapeutics, Inc.$7.21M0.89%0.47%+28.8%Q2 2017
MLYSMineralys Therapeutics, Inc.$7.13M0.88%0.32%+84.5%Q3 2025
IONSIonis Pharmaceuticals Inc$6.98M0.86%0.06%-41.4%Q4 2015
DNTHDianthus Therapeutics, Inc.$6.85M0.85%0.15%-17.2%Q3 2024
BBIOBridgeBio Pharma, Inc.$6.73M0.83%0.05%+11.0%Q1 2023
Q4 2025Reported Feb 13, 202694 positions
REGNRegeneron Pharmaceuticals, Inc.$47.4M4.43%0.07%+70.1%Q4 2013
LLYELI LILLY & Co$45.4M4.24%0.00%-21.0%Q4 2013
BSXBoston Scientific Corp$41.1M3.84%0.03%-1.6%Q4 2013
MDTMedtronic plc$28.4M2.66%0.02%+44.4%Q4 2013
ISRGIntuitive Surgical Inc$27.2M2.54%0.01%-1.0%Q4 2013
COOCooper Companies, Inc.$26.8M2.51%0.17%+38.2%Q2 2015
CVSCVS HEALTH Corp$26.6M2.49%0.03%+21.0%Q4 2013
ABBVAbbVie Inc.$25.3M2.36%0.01%-15.2%Q1 2014
GKOSGLAUKOS Corp$23.7M2.22%0.37%-8.7%Q2 2016
DHRDanaher Corp$22.7M2.12%0.01%-26.3%Q4 2021
CORCencora, Inc.$21.4M2.00%0.03%+1.6%Q4 2013
VERAVera Therapeutics, Inc.$21.3M1.99%0.66%+223.1%Q3 2025
MCKMckesson Corp$21M1.96%0.02%-3.8%Q4 2013
AXSMAxsome Therapeutics, Inc.$21M1.96%0.23%-33.6%Q1 2023
ALHCAlignment Healthcare, Inc.$19.9M1.86%0.49%-31.8%Q3 2022
INSMINSMED Inc$19.8M1.85%0.05%-13.9%Q2 2024
TMOThermo Fisher Scientific Inc.$19.5M1.82%0.01%+12.0%Q4 2013
PRCTPROCEPT BioRobotics Corp$19.2M1.80%1.08%+56.7%Q2 2023
ALNYAlnylam Pharmaceuticals, Inc.$18.2M1.70%0.03%+43.3%Q3 2014
UNHUnitedhealth Group Inc$18.1M1.69%0.01%-12.2%Q4 2013
NBIXNeurocrine Biosciences Inc$17.8M1.66%0.13%+9.4%Q1 2016
PODDInsulet Corp$17.3M1.62%0.09%+5.2%Q4 2013
DOCSDoximity, Inc.$16.5M1.54%0.20%+174.1%Q2 2025
EWEdwards Lifesciences Corp$16.5M1.54%0.03%+24.8%Q1 2014
NUVLNuvalent, Inc.$16.4M1.54%5.22%+211.1%Q4 2022
BIIBBiogen Inc.$16.3M1.52%0.06%+67.9%Q4 2013
VRTXVertex Pharmaceuticals Inc / Ma$15.5M1.45%0.01%-27.1%Q2 2014
EHCEncompass Health Corp$15.5M1.45%0.15%+22.5%Q1 2024
GILDGilead Sciences, Inc.$15.5M1.45%0.01%+57.4%Q4 2013
ALGNAlign Technology Inc$15.5M1.44%0.14%+19.3%Q4 2021
THCTenet Healthcare Corp$15.2M1.42%0.09%+30.9%Q2 2021
BMRNBiomarin Pharmaceutical Inc$12.8M1.19%0.11%+15.2%Q4 2013
JAZZJazz Pharmaceuticals plc$12.6M1.18%0.12%-22.1%Q3 2014
IONSIonis Pharmaceuticals Inc$12.5M1.17%0.10%-48.9%Q4 2015
AMGNAmgen Inc$11.8M1.10%0.01%Not reportedQ1 2014
LIVNLivaNova PLC$11.7M1.09%0.35%+258.5%Q4 2015
MDGLMadrigal Pharmaceuticals, Inc.$11.4M1.06%0.09%+7.1%Q1 2019
CICigna Group$10.6M0.99%0.01%-16.9%Q4 2013
GPCRStructure Therapeutics Inc.$10.3M0.96%0.07%-18.1%Q1 2025
SNDXSyndax Pharmaceuticals Inc$10.2M0.96%0.56%-15.2%Q1 2024
NRIXNurix Therapeutics, Inc.$10.2M0.95%0.53%+54.7%Q2 2024
PNTGPennant Group, Inc.$10.1M0.94%1.03%NewQ4 2025
ADPTAdaptive Biotechnologies Corp$9.83M0.92%0.39%+22.2%Q3 2025
PENPenumbra Inc$9.79M0.92%0.08%+53.7%Q4 2023
ARWRArrowhead Pharmaceuticals, Inc.$9.59M0.90%0.11%NewQ4 2025
APLSApellis Pharmaceuticals, Inc.$9.41M0.88%0.30%+61.2%Q4 2019
NTRANatera, Inc.$9.28M0.87%0.03%+30.7%Q3 2022
KURAKura Oncology, Inc.$9.06M0.85%0.99%+78.0%Q1 2024
ACLXArcellx, Inc.$8.7M0.81%0.23%+104.6%Q3 2024
IDYAIDEAYA Biosciences, Inc.$8.64M0.81%0.28%Not reportedQ2 2024
Q3 2025Reported Nov 13, 202592 positions
BSXBoston Scientific Corp$42.8M4.73%0.03%+48.0%Q4 2013
LLYELI LILLY & Co$40.8M4.51%0.01%-7.7%Q4 2013
ABBVAbbVie Inc.$30.2M3.34%0.01%+87.9%Q1 2014
DHRDanaher Corp$26.7M2.95%0.02%+10.7%Q4 2021
ALHCAlignment Healthcare, Inc.$25.8M2.86%0.74%+14.9%Q3 2022
ISRGIntuitive Surgical Inc$21.7M2.40%0.01%+9.4%Q4 2013
UNHUnitedhealth Group Inc$21.6M2.39%0.01%+105.5%Q4 2013
AXSMAxsome Therapeutics, Inc.$21M2.32%0.34%+90.3%Q1 2023
CVSCVS HEALTH Corp$20.9M2.31%0.02%-6.1%Q4 2013
MCKMckesson Corp$20.5M2.27%0.02%-4.0%Q4 2013
REGNRegeneron Pharmaceuticals, Inc.$20.3M2.25%0.04%+30.3%Q4 2013
IONSIonis Pharmaceuticals Inc$20.3M2.24%0.19%+70.3%Q4 2015
MDTMedtronic plc$19.5M2.16%0.02%+14.2%Q4 2013
CORCencora, Inc.$19.5M2.16%0.03%+26.3%Q4 2013
EXKEndeavour Silver Corp$19M2.11%0.13%-0.6%Q1 2019
INSMINSMED Inc$19M2.10%0.06%-24.8%Q2 2024
GKOSGLAUKOS Corp$18.8M2.08%0.40%-2.1%Q2 2016
VRTXVertex Pharmaceuticals Inc / Ma$18.4M2.03%0.02%-23.6%Q2 2014
PODDInsulet Corp$17.9M1.98%0.08%+26.1%Q4 2013
COOCooper Companies, Inc.$16.2M1.80%0.12%+39.4%Q2 2015
NBIXNeurocrine Biosciences Inc$16.1M1.78%0.12%-23.1%Q1 2016
EHCEncompass Health Corp$15.2M1.68%0.12%-12.5%Q1 2024
CAHCardinal Health Inc$14.8M1.63%0.04%+70.9%Q2 2014
TMOThermo Fisher Scientific Inc.$14.6M1.61%0.01%+169.7%Q4 2013
ALNYAlnylam Pharmaceuticals, Inc.$14.5M1.61%0.02%-37.7%Q3 2014
CYTKCytokinetics Inc$14M1.55%0.21%+144.8%Q4 2021
PRCTPROCEPT BioRobotics Corp$13.9M1.54%0.70%+105.3%Q2 2023
CICigna Group$13.4M1.48%0.02%+45.3%Q4 2013
ABTAbbott Laboratories$13.2M1.46%0.01%+68.4%Q2 2016
JAZZJazz Pharmaceuticals plc$12.5M1.39%0.16%-12.8%Q3 2014
EWEdwards Lifesciences Corp$12.1M1.33%0.03%+181.8%Q1 2014
THCTenet Healthcare Corp$11.9M1.31%0.07%-57.2%Q2 2021
AKROAkero Therapeutics, Inc.$10.9M1.21%0.29%+16.7%Q1 2025
ALGNAlign Technology Inc$10.4M1.15%0.12%+24.8%Q4 2021
BMRNBiomarin Pharmaceutical Inc$10.1M1.12%0.10%+24.7%Q4 2013
DOCSDoximity, Inc.$9.95M1.10%0.07%+547.6%Q2 2025
RPRXRoyalty Pharma plc$9.12M1.01%0.07%-24.9%Q4 2020
GILDGilead Sciences, Inc.$8.9M0.98%0.01%-52.3%Q4 2013
SNDXSyndax Pharmaceuticals Inc$8.83M0.98%0.66%Not reportedQ1 2024
MDGLMadrigal Pharmaceuticals, Inc.$8.37M0.93%0.08%Not reportedQ1 2019
BIIBBiogen Inc.$7.7M0.85%0.04%+358.3%Q4 2013
DVAXDynavax Technologies Corp$7.67M0.85%0.66%+36.6%Q4 2013
ADPTAdaptive Biotechnologies Corp$7.41M0.82%0.32%NewQ3 2025
ELVElevance Health, Inc.$7.27M0.80%0.01%-49.6%Q4 2014
DNTHDianthus Therapeutics, Inc.$6.83M0.76%0.41%+37.1%Q3 2024
MLYSMineralys Therapeutics, Inc.$6.26M0.69%0.21%NewQ3 2025
CNCCentene Corp$6.07M0.67%0.03%+70.4%Q4 2013
STOKStoke Therapeutics, Inc.$5.88M0.65%0.45%NewQ3 2025
VKTXViking Therapeutics, Inc.$5.68M0.63%0.19%+154.5%Q2 2019
AVRAnteris Technologies Global Corp.$5.63M0.62%3.47%Not reportedQ1 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.